Skip to content
Kreastel
Opening soon

miglustat (for treatment of Pompe disease)

As the list published 4 Feb 2026 has it, binding since 22 Apr 2026. Each entry binds six months after its own publication date (Article 107c(7) of Directive 2001/83/EC).

What the list says

EU reference date
20 Mar 2023
PSUR frequency
1 year
Data lock point
19 Mar 2026
Submission date
28 May 2026
Next data lock point
19 Mar 2027
Next submission date
28 May 2027
Products covered
Centrally authorised (CAP)

Are PSURs required for products referred to in Articles 10(1), 10a and 16a of Directive 2001/83/EC?

No — the list does not require PSURs for these products.

The list asks this as one question for Articles 10(1), 10a and 16a together, and does not answer it for Article 14 at all. A PSUR may in any case be required at the request of a competent authority or as a condition of the marketing authorisation.

Notes in the list

DLP was amended on 22/10/2025

Changing

The list published 23 Sept 2026 changes this entry. Those values bind from 2 Dec 2026, six months after the change was published (Article 107c(7) of Directive 2001/83/EC). Until then, what is above applies.

Changing
FieldApplies todayFrom the date above
NotesDLP was amended on 22/10/2025Not stated

Track dates like these for your own products: a sample workspace, read-only, no account needed.

Try the demo

The next three reports

  • Data lock point 19 Mar 2027Submission by 28 May 2027
  • Data lock point 19 Mar 2028Submission by 28 May 2028
  • Data lock point 19 Mar 2029Submission by 28 May 2029

Counted from the data lock point the list gives, on the cycle it states: the submission date is 70 days after the data lock point — 70 days for a cycle of twelve months or less, 90 days for a longer one, as GVP Module VII sets out.

In earlier versions of the list

  • EMA/630645/2012 Rev.164 · published 23 Sept 2026

    miglustat (for treatment of Pompe disease) — every 1 year, data lock point 19 Mar 2027

  • EMA/630645/2012 Rev.156 · published 4 Feb 2026

    miglustat (for treatment of Pompe disease) — every 1 year, data lock point 19 Mar 2027

Source: European Medicines Agency, list of EU reference dates and frequency of submission of periodic safety update reports, EMA/630645/2012 Rev.156, published 4 Feb 2026. Open the published file

Kreastel is a planning and oversight aid for pharmacovigilance obligations. It tracks dates like these for a marketing authorisation holder's own products.

Report a discrepancy — if this page and the published file disagree, the file is right and we want to know.

Kreastel